More Than a Protocol: Designing Patient-Centric Trials for Rare Diseases
For sponsors working in the rare disease space, the challenge is immense. With small patient populations, geographically scattered individuals, and
For sponsors working in the rare disease space, the challenge is immense. With small patient populations, geographically scattered individuals, and